Superior hepatic mitochondrial oxidation-reduction state in normothermic cardiopulmonary bypass  by Hashimoto, Kazuhiro et al.
The risk of possible hepatic failure complicates the
decision to proceed with surgery in these patients. The
preoperative condition of the liver is the most influen-
tial factor.1 However, the severity of postoperative liver
damage is also strongly influenced by cardiopulmonary
bypass (CPB) conditions, such as the perfusion pres-
sures and the duration of the CPB.1,2 Therefore, ade-
quate perfusion of the liver and the maintenance of
energy charge potentials in hepatocytes are also consid-
ered to be important during CPB.
Hypoperfusion of the liver during CPB has always
been considered as a cause of liver damage, but only a
few clinical hemodynamic studies focusing on hepatic
blood flow and hepatic oxygen metabolism have been
T he condition of patients who have a long history ofcongestive heart failure is sometimes complicated
by hepatic dysfunction. Acute aggravation of liver func-
tion, characterized by sharp increases in the serum con-
centrations of transaminases and bilirubin, is infrequent
but does occasionally occur after cardiac operations.
Objective: This study is the first comparative investigation of hepatic blood
flow and oxygen metabolism during normothermic and hypothermic car-
diopulmonary bypass.
Methods: Twenty-four patients undergoing coronary bypass operations were
randomly divided into 2 groups according to their perfusion temperatures,
either normothermia (36°C) or hypothermia (30°C). The clearance of indo-
cyanine green was measured at 3 points. Arterial and hepatic venous ketone
body ratios (an index of mitochondrial redox potential) and hepatic venous
saturation were measured.
Results: Hepatic blood flow in both groups was identical before, during, and
after cardiopulmonary bypass (normothermia, 499 ± 111, 479 ± 139, and 563
± 182 mL/min, respectively; hypothermia, 476 ± 156, 491 ± 147, and 560 ±
202 mL/min, respectively). The hepatic venous saturation levels were signif-
icantly lower during cardiopulmonary bypass in the normothermic group
(normothermia, 41% ± 13%; hypothermia, 61% ± 18%; P < .01), indicating
a higher level of oxygen extraction use. The arterial ketone body ratio in the
hypothermic group decreased severely after the onset of cardiopulmonary
bypass (P < .01) and did not return to its subnormal value (>0.7) until the sec-
ond postoperative day. However, the reduction in arterial ketone body ratio
was less severe in the normothermic group. The difference in hepatic venous
ketone body ratios was more obvious, and the hepatic venous ketone body
ratios in the normothermic group were statistically superior to those of the
hypothermic group throughout the course (P < .05-.01).
Conclusions: Normothermic cardiopulmonary bypass provides adequate
liver perfusion and results in a better hepatic mitochondrial redox potential
than hypothermic cardiopulmonary bypass. Because arterial ketone body
ratios reflect hepatic energy potential, normothermia was considered to be
physiologically more advantageous for hepatic function.  (J Thorac
Cardiovasc Surg 2001;121:1179-86)
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performed.3-6 The arterial ketone body ratio (AKBR,
the ratio of acetoacetate/3-hydroxybutyrate) reflects the
mitochondrial oxidation-reduction (redox) potential7
and has been proposed to be an indicator not only of
liver dysfunction, but also of dysfunction throughout
the entire body.7-11 The effect of different CPB perfu-
sion temperatures on AKBR has not been examined.
This study was designed (1) to investigate the relation
between perfusion temperature and hepatic blood flow
and between perfusion temperature and hepatic venous
oxygen saturation during CPB and (2) to clarify how
hepatic mitochondrial function is affected by the perfu-
sion temperature during and after CPB. 
Subjects and methods
Twenty-four patients undergoing elective coronary bypass
surgery were selected after we had obtained the approval of
our institution’s ethics committee and had received the writ-
ten informed consent of the patients. None of the patients had
congestive heart failure or liver disease. The patients were
randomly selected by the perfusionists and divided into 2
groups (12 patients in each group) according to their CPB
perfusion temperature, either normothermic (36°C) or
hypothermic (30°C). Two surgeons performed the operations,
and surgeons were not informed of the perfusion temperature.
Anesthesia was induced by intravenous injection of fen-
tanyl (10 µg/kg), vecuronium (0.2 mg/kg), and midazolam
(0.05 mg/kg), and each patient was intubated. Intravenous
infusion of propofol (4 mg · kg–1 · h–1) was then commenced
and continued until the end of operation. The total dose of
fentanyl used during operation was 25 to 30 µg/kg. Once the
patient was anesthetized, a pulmonary artery catheter
(Vigilance Swan-Ganz CCO Thermodilution Catheter;
Baxter Healthcare Corp, Irvine, Calif) was inserted through
the right internal jugular vein. A hepatic catheter for obtain-
ing blood samples from the hepatic vein was inserted through
the left or right femoral vein. The position of the catheter was
verified radiographically. The CPB was performed with a
nonpulsatile flow at the constant flow rate, around 2.5 L ·
min–1 · m–2, irrespective of the perfusion temperature. The
patients’ arterial blood gases were monitored by alpha-stat
control. A membrane oxygenator with hollow polypropylene
fibers and polyvinyl chloride tubing was used in both groups.
The prime volumes were the same in both groups and con-
sisted of 1600 mL of electrolyte solution, 50 mL of 7% sodi-
um bicarbonate, and 20 g of mannitol. The hematocrit level
was maintained at more than 20% throughout the CPB, with
blood added as necessary. The perfusion pressures were
maintained at 60 to 70 mm Hg in both groups. Phenylephrine
and nitroglycerin were used to control the pressure during the
CPB. A cold blood cardioplegic solution was delivered ante-
gradely and retrogradely. The pericardial well was soaked
with cold saline solution (without ice) for topical cooling. All
anastomoses in the coronary bypass operation, proximal and
distal, were performed during single aortic clamping.
Measurements
Hepatic blood flow. The cardiac output was measured 3
times at 5-minute intervals during the pre-CPB and the post-
CPB periods. The values were then averaged. During CPB
the perfusion flow of the CPB machine was recorded.
The clearance of indocyanine green (ICG)12 was measured
3 times during the following periods: (1) after the induction
of anesthesia (before CPB), (2) during CPB, and (3) after the
cessation of CPB. An ICG dose of 6 mg was first introduced
by intravenous bolus injection before and after CPB or direct-
ly into the pump-oxygenator during CPB. After the bolus
injection, ICG was continuously injected at a speed of 1
mg/min. Blood samples were taken from the peripheral arte-
rial and hepatic venous lines at 10, 20, and 30 minutes after
the bolus injection. The blood was immediately transferred to
empty tubes and centrifuged for 15 minutes at 1700g. The
absorbance of the plasma samples was read spectrophoto-
metrically at 805 and 900 nm, the absorbance at 900 nm
being used to correct for turbidity. The concentration of ICG
was calculated from the corrected absorbance at 805 nm by
means of a standard curve constructed from human plasma
containing known concentrations of ICG. Hepatic blood flow
was calculated by means of the following formula: Hepatic
blood flow (mL/min) = I/(Ca-Cv) × 100/(100-Ht), where I is
the speed of the ICG injection (mg/min), Ca is the mean con-
centration of arterial ICG (mg/mL), Cv is the mean concen-
tration of hepatic venous ICG (mg/mL), and Ht is the hemat-
ocrit value (%). The results were expressed as the absolute
flow value, the average of 3 measurements (mL/min), and a
percentage of the cardiac output.
Arterial and hepatic ketone body ratios. Arterial and hepat-
ic venous samplings to measure the AKBR and hepatic
venous ketone body ratios (HKBR) were performed at 9 time
points: (1) after the induction of anesthesia (baseline data),
(2) 10 minutes after the initiation of the CPB, (3) 60 minutes
after the initiation of the CPB, (4) during the warming period
in the hypothermic group or at the time of aortic unclamping
in the normothermic group, (5) at the end of CPB, (6) at the
time of admission to the intensive care unit (ICU), (7) 6 hours
after the ICU admission, (8) first postoperative day, and (9)
second postoperative day. The commercially available
Ketorex kit (Sanwa Kagaku Kenkyusho Co, Ltd, Nagoya,
Japan) was used to measure the ketone body ratios.
Acetoacetate and 3-hydroxybutyrate concentrations were
measured enzymatically.
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Table I. Patient profile
Normothermia Hypothermia
(n = 12) (n = 12)
Age (y) 66 ± 7 68 ± 7
Sex (M/F) 11/1 10/2
Height (cm) 162 ± 7 159 ± 9
Body weight (kg) 65 ± 7 63 ± 9
CPB time (min) 140 ± 30 148 ± 31
Aortic clamp time (min) 116 ± 31 113 ± 35
No significance between 2 groups.
Oxygen saturation of arterial, mixed venous, and hepatic
venous blood. Samples were obtained from the radial arteri-
al, hepatic venous, and the distal tip of the Swan-Ganz
catheters. Arterial (SaO2), mixed venous (SvO2) and hepatic
venous O2 saturation (ShvO2) levels were measured at the
same 9 time points described above for the ketone body ratio
measurements. Blood gas analyses were performed with the
Stat Profile Ultima device (Nova Biomedical, Waltham,
Mass).
Other blood samples. Blood samples for measuring ala-
nine aminotransferase (ALT), rapid turnover proteins (trans-
ferrin and transthyretin), ammonia, and tumor necrosis fac-
tor–α (TNF-α) levels were withdrawn from the hepatic
venous catheter and transferred to appropriate sample tubes.
The samples were taken after the induction of anesthesia, at
the termination of the CPB, and at the time of admission to
the ICU. The lactate level in the hepatic venous blood was
also measured at the same 9 time points described above for
ketone body ratio measurements. All of the blood samples,
including the samples that were taken for the measurement of
ICG clearance, were immediately centrifuged. The plasma
was stored at –70°C for laboratory assay. All plasma samples
were forwarded to the laboratory assay company (Sumitomo
Bio-Science, Omiya, Japan). Transferrin and transthyretin
levels were measured by nephelometry. Ammonia and TNF-
α levels were measured with enzyme immunoassays. The
lactate level was also measured enzymatically.
Patients were excluded from this study for the following
reasons: (1) emergency cases, (2) history of previous cardiac
operations, (3) coexistence of valvular heart disease, (4) renal
failure, (5) cerebrovascular or lung disease, and (6) hepatic
disease.
Statistical analysis. All data are expressed as the mean ±
standard deviation. Comparisons of the patient characteristics
were made with the Student t test or χ2 test. Two-way analy-
sis of variance with adjustment for repeated measures was
used for intergroup comparison. The calculated significant
probabilities were adjusted by the Dunnett multicomparison
method to control type I errors. Analysis of variance with
Bonferroni/Dunn multicomparison method as a post hoc test
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Table II. Hepatic blood flow
Hepatic blood flow (mL/min) % value of CO
Pre-CPB During CPB Post-CPB Pre-CPB During CPB Post-CPB
Normothermia 499 ± 111 479 ± 139 563 ± 182 12 ± 3 12 ± 3 11 ± 6
Hypothermia 476 ± 156 491 ± 147 560 ± 202 13 ± 4 11 ± 4 11 ± 7
No significance among Pre-, During, and Post-CPB for either group. No significance between 2 groups. CO, Cardiac output.
Fig 1. The AKBR in both groups decreased after the onset of CPB and continued to remain at a significantly low level
throughout CPB. However, the AKBR in the normothermic group was better than that of the hypothermic group. *P
< .05, **P < .01 vs anesthesia; #P < .05, ##P < .01 between 2 groups. Ane, After anesthesia; CPB10, 10 minutes after
CPB; 60m, 60 minutes after CPB; Warm, during the warming period in the hypothermic or at the aortic declamping in
the normothermic group; Off, end of CPB; ICU, ICU admission; 6h, 6 hours in ICU; 1day, first postoperative day;
2day, second day.
was used for intragroup comparison. Analyses were per-
formed with SPSS 6.1 (SPSS Inc, Chicago, Ill) for the
Macintosh PowerMac (Apple Computer, Cupertino, Calif).
Results 
The baseline characteristics of the study participants
are listed in Table I. The groups were matched with
regard to all preoperative demographic and operative
variables.
Hepatic blood flow. Hepatic blood flow and its per-
centage of the cardiac output are listed for the 2 groups
in Table II. The data did not show any significant dif-
ferences among the pre-CPB, during CPB, and post-
CPB values for either group. Values for corresponding
periods between the 2 groups also showed no statistical
differences.
AKBRs and HKBRs (Figs 1 and 2). The values of
AKBR after the induction of anesthesia were 0.73 ±
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Fig 2. The reduction in the HKBR of the normothermic group was not significant to the value after anesthesia
(Ane). The ratios were statistically better than those of the hypothermic group throughout the measurement period.
**P < .01 vs anesthesia; #P < .05, ##P < .01 between 2 groups. CPB10, 10 minutes after the CPB; 60m, 60 min-
utes after CPB; Warm, during the warming period in the hypothermic group or at the aortic declamping in the
normothermic group; Off, end of CPB; ICU, ICU admission; 6h, 6 hours in the ICU; 1day, first postoperative day;
2day, second day.
Table III. Oxygen metabolism (%) and lactate levels (mmol/L)
CPB CPB Warm CPB
Anesthesia 10 min 60 min (aorta unclamp) off ICU ICU 6 h 1 day 2 day
Normothermia
SaO2 100 100 100 100 100 100 99 ± 0.6 99 ± 1.0 98 ± 3
SvO2 84 ± 6 81 ± 4 77 ± 3*§ 77 ± 4* 83 ± 5 84 ± 5 69 ± 8† 70 ± 7† 69 ± 10*
ShvO2 80 ± 7 39 ± 16†‡ 41 ± 13†§ 36 ± 13† 65 ± 11†§ 74 ± 12 66 ± 7† 69 ± 9† 60 ± 16
Lactate 0.8 ± 0.6 1.7 ± 0.9† 2.0 ± 1.3† 2.3 ± 1.5† 3.1 ± 2.1† 3.4 ± 2.1† 3.9 ± 2.0† 1.8 ± 1.6† 1.3 ± 0.3*
Hypothermia
SaO2 100 100 100 100 100 100 99 ± 0.8 99 ± 1.4 98 ± 1.6
SvO2 83 ± 5 83 ± 12 86 ± 5 77 ± 3† 83 ± 6 83 ± 6 71 ± 8† 70 ± 7† 70 ± 5†
ShvO2 81 ± 12 58 ± 20† 61 ± 18† 46 ± 22† 76 ± 6 77 ± 11 71 ± 13* 69 ± 12 69 ± 6
Lactate 0.8 ± 0.8 2.1 ± 0.7† 2.5 ± 0.8† 2.7 ± 1.2† 4.1 ± 1.0† 4.2 ± 1.2† 5.3 ± 1.5† 2.4 ± 0.6† 1.6 ± 0.4†
SaO2, Arterial oxygen saturation; SvO2, mixed venous oxygen saturation; ShvO2, hepatic venous oxygen saturation.
*P < .05 versus anesthesia.
†P < .01 versus anesthesia.
‡P < .05 between normothermia and hypothermia.
§P < .01 between normothermia and hypothermia.
0.27 for the normothermic and 0.69 ± 0.15 for the
hypothermic group, which were lower limit of normal
(normal range, >1.0; subnormal range, 0.7-1.0).
Irrespective of the perfusion temperature (36.5°C or
30°C), the AKBR decreased significantly after the
onset of the CPB (P < .01). The AKBRs in both groups
continued to remain at a significantly low level
throughout the CPB (P < .01 to .05 vs after anesthe-
sia). The AKBR of the hypothermic group did not
return to a normal level until the final measurement
performed on the second postoperative day. However,
the AKBR in the normothermic group was better than
that of the hypothermic group during CPB throughout
the measurement period (P < .1 or P < .01 to .05) and
returned to a normal level (0.88 ± 0.18) on the first
postoperative day.
Although the same pattern of changes was observed
for the HKBRs during and after CPB, the reduction in
the HKBR of the normothermic group was not signifi-
cantly different from the value after anesthesia. The
ratios were statistically better than those of the
hypothermic group throughout the measurement period
after the initiation of CPB (P < .01 to .05). The values
returned to normal after the time of ICU admission in
the normothermic group but did not return until first
postoperative day in the hypothermic group.
Oxygen saturations of arterial, mixed venous and
hepatic venous blood. The oxygen saturation data are
listed in Table III. The SaO2 levels were nearly 100% in
both groups throughout the period of measurement. In
the hypothermic group the SvO2 values during the
rewarming period and 6 hours after the time of ICU
admission were statistically lower than the postanes-
thesia values (P < .01). On the other hand, a significant
reduction in SvO2 was additionally observed during the
CPB in the normothermic group (P < .05). The SvO2
values in both groups were almost identical for corre-
sponding time periods except for the statistically lower
value obtained 60 minutes after the induction of the
CPB in the normothermic group (P < .01). The ShvO2
levels during the CPB were significantly lower than the
postanesthesia levels in both groups (P < .01). The
reductions in the ShvO2 levels of the normothermic
group were statistically significant at 10 and 60 min-
utes after the initiation of CPB and at the cessation of
CPB compared with the values of hypothermic group
(P < .01 to .05). However, no differences were ob-
served for any other time periods.
Other blood samples. The blood sample results are
listed in Table IV. The ALT and TNF-α values did not
change after the CPB. However, the ammonia level
increased after the CPB (P < .01). The transferrin and
transthyretin levels decreased after CPB and at the time
of ICU admission (P < .01). However, no differences
between the normothermic and hypothermic groups
were observed for corresponding time periods in the
above measurements. The lactate value increased
promptly after the initiation of the CPB and continued
throughout the measuring periods (P < .01 to .05) in
both groups (Table III). The levels in the normothermic
group were somewhat lower than those of the
hypothermic group, but the difference was not statisti-
cally significant.
Discussion
Sufficient oxygen delivery to meet organ demands is
an important factor for protecting the organs during
CPB. Systemic hypothermia during CPB has been
regarded as an essential measure that offers some degree
of organ protection.13 However, some disadvantages of
hypothermic CPB have been suggested,13 and the use of
normothermic CPB has been reported to confer advan-
tages over conventional hypothermic CPB.14-16 Several
studies have been performed on the vulnerability of the
brain to ischemia during normothermic CPB.17,18
However, few data are available on the effect of nor-
mothermic and hypothermic perfusion on the liver.
This study was performed in patients with a single
condition and without evidence of congestive heart
failure or hepatic disease, so that we could examine
patients who had a normal liver and avoid differences
of preoperative liver function. The study shows that
perfusion temperature does not alter hepatic blood
flow. Mathie and colleagues6 investigated the effects of
different perfusion temperatures and of pulsed versus
nonpulsed perfusion on hepatic blood flow and came to
the same conclusion. Waldhausen and colleagues3 also
concluded that normal blood flow could be maintained
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Table IV. Results of blood samples
Anesthesia CPB off ICU
Normothermia
ALT (IU/L) 25 ± 12 18 ± 7 18 ± 4
Transferrin (mg/dL) 199 ± 35 122 ± 24* 130 ± 52*
Transthyretin (mg/dL) 19 ± 6 13 ± 4* 15 ± 4*
Ammonia (µg/dL) 12 ± 5 20 ± 4* 21 ± 9*
TNF-α (pg/mL) 18 ± 11 17 ± 10 17 ± 6
Hypothermia
ALT (IU/L) 26 ± 11 20 ± 8 22 ± 9
Transferrin (mg/dL) 191 ± 18 119 ± 18* 132 ± 48*
Transthyretin (mg/dL) 21 ± 4 13 ± 4* 16 ± 2*
Ammonia (µg/dL) 11 ± 8 25 ± 13* 21 ± 13*
TNF-α (pg/mL) 14 ± 5 20 ± 15 18 ± 9
*P < .01 vs anesthesia. No significance between 2 groups.
at a flow rate of 2.2 L · min–1 · m–2 during CPB.
Because the arterial oxygen saturation and hepatic
blood flow in both the normothermic and the hypother-
mic groups were identical, the value of hepatic venous
saturation was remarkably reduced in the normother-
mic group, indicating that a larger amount of oxygen
was extracted in normothermic livers than in hypother-
mic livers. Koizumi19 examined experimental dog
models and concluded that hepatic blood flow was
slightly reduced during CPB, irrespective of perfusion
temperature, as a result of the exclusive reduction in
portal venous blood flow. However, Koizumi found that
hepatic venous oxygen uptake was well maintained by
an increase in the oxygen uptake ratio. Another investi-
gation by Yamada and colleagues5 involving Doppler
measurements of portal venous flow in human beings
concluded differently. In Yamada’s study no reductions
in portal venous flow were observed throughout CPB.
The reduction of acetoacetate to 3-hydroxybutyrate is
a key metabolic reaction that takes place within liver
mitochondria and involves the production of energy-
rich ketone bodies. The ratio of these 2 acids is termed
the ketone body ratio and is regarded as a marker of
hepatic energy or the redox potential of the liver mito-
chondria.7 This theory is based on the fact that the equi-
librium between the concentrations of acetoacetate and
3-hydroxybutyrate reflects the ratio of NAD+/NADH
(oxidized nicotinamide adenine dinucleotide/reduced
nicotinamide adenine dinucleotide dehydrogenase) in
the mitochondria. Recent studies of the utility of the
AKBR have been called into question. In anhepatic
phase (in liver transplantation, during clamping of
hepatic artery and portal vein in hepatectomy), each of
the 2 types of ketone body is metabolized to a different
extent in extrahepatic tissues. These results were
reported by Matsushita and colleagues.20 In this study,
however, the livers were always perfused and we also
measured the hepatic ketone body ratio, which is more
accurate and less influenced by metabolism in extra-
hepatic tissues.21
The AKBR value before CPB was expected to be
more than 1.0. However, the data obtained in both
groups were at the lower limit of normal and were con-
sidered to be influenced by anesthesia, because both
groups demonstrated normal values at the final mea-
surement. The pattern of AKBR changes in the nor-
mothermic CPB group was better than that of the
hypothermic group. The higher values and earlier
recovery of the AKBR value during and after the CPB
suggest that the metabolic integrity of the liver was bet-
ter maintained in the normothermic group. As the
ketone bodies newly produced by the liver are trans-
ported to the right side of the heart via the hepatic vein,
HKBRs reflect more accurately.21
The HKBR values obtained from the hepatic venous
blood showed a clearer benefit to the mitochondrial
redox potential in the normothermic CPB group. The
decrease of HKBR ratios during CPB was small (not
significant), and recovery was faster than in the
hypothermic group. These findings suggest that nor-
mothermic perfusion is preferable with regard to the
maintenance of liver metabolism and liver protection
during CPB. Hypothermic perfusion appears to have
suppressed the liver metabolic cycle during CPB and
delayed the restoration of normal liver function after
CPB. The reduction in ShvO2 values observed during
normothermic CPB reflected the extraction of oxygen
but was not low enough to cause ischemia. Takano and
colleagues22 reported that ShvO2 is a useful indicator
for predicting acute hepatic failure after Fontan opera-
tions. A critical value was set at below 25% during the
first 24 hours after the operation. In this study none of
the patients exhibited a value below 25% after the oper-
ation, but 3 patients in the normothermic group and 2
patients (during the warming period) in the hypother-
mic group exhibited a value of less than 25% for a short
period of time during CPB. Of course, another impor-
tant factor leading to liver damage, central venous pres-
sure, was much lower in this study than post-Fontan
operation values. Events of reduced Shvo2 were not
considered detrimental to cause malfunction of the
liver in the normothermic CPB.
ALT is a common leaking enzyme that is released by
destroyed hepatocytes. Rapid turnover proteins (trans-
ferrin and transthyretin) produced by hepatocytes are
synthesized on polyribosomes bound to the rough
endoplasmic reticulum. A decrease in the concentration
of these proteins reflects a decrease in hepatic synthe-
sis. Amino acids are metabolized to ammonia and urea
by the Krebs-Henseleit urea cycle in the liver. An
increase in serum ammonia levels represents a failure
of the Krebs-Henseleit cycle. TNF-α is one of the
cytokines released by activated Kupffer cells and acts
as a trigger for liver damage after ischemia. Lactate is
an end product of glycogen in the muscle and is metab-
olized in the liver, mainly by gluconeogenesis. An
increase in lactate levels indicates metabolic failure in
the liver. Overall, the results concerning the above indi-
cators suggest that some early changes in liver func-
tioning might be occurring, but no significant differ-
ences were detected between the 2 groups. The ketone
body ratios (particularly HKBR) were, however, sensi-
tive enough to show a difference in liver function. The
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abnormalities of other indicators measured in this study
of course occurred under the circumstance of a low
AKBR (not necessarily induced by liver disease, but
also by systemic dysfunction such as shock, hypoxia,
and hemodilution).23,24 The AKBR indicates the hepat-
ic energy reserve but does not always reflect the mag-
nitude of hepatocellular damage or particular deficits
among several aspects of liver function. Normal hepat-
ocytes can produce additional energy as compensation
for damaged cells. However, failure of compensation
finally results in lethal dysfunction and liver damage.
This might be a reason why there was a difference in
results between the usual liver function markers and the
AKBR. The hepatic damage induced by CPB is usual-
ly small in normal livers and cannot be considered as a
serious side effect. However, the low ketone body ratio
during CPB may induce serious hepatic complications
in patients with pre-existing liver damage.
Recently, we25 and others26,27 investigated the influ-
ence of CPB temperature on circulatory pathophysiol-
ogy. The activation of blood components and various
vasoactive substances did not vary with the perfusion
temperature (36°C or 30°C). None of the above inves-
tigators have shown that normothermic CPB results in
a better physiologic body response, but several clinical
advantages have been documented, including the
preservation of coagulation processes and a reduction
in bleeding, hemodynamic stability, and a shorter peri-
od of intubation.14-16,25 An impaired turnover of the tri-
carboxylic cycle has a large effect on glucose metabo-
lism, so a good theoretical argument exists for using
ketone body ratio to reflect the metabolic integrity of
the entire body.7 The reduction of energy in hepato-
cytes decreases energy supply at the mitochondria in
the other organs. A decrease in this ratio inevitably
leads to the destruction of muscle protein, which results
in the accumulation of lactate and amino acids in the
blood. Considerable evidence exists suggesting that
AKBR is closely correlated with hemorrhagic shock,
hypoxia, and hemodilution.23,24 It has also been recog-
nized that the hepatic mitochondria influence the role
of platelets, neutrophils, and lymphocytes.28 Nomoto
and colleagues8 demonstrated that in patients undergo-
ing cardiac surgery requiring prolonged respiratory or
circulatory support, AKBR recovery was slower than in
normal convalescent patients. Complement activation
has been reported to be related to the morbidity associ-
ated with cardiac surgery.13 Influence of hepatic mito-
chondrial redox state on complement biosynthesis and
activation was also investigated during and after CPB.
The complement activation and consumption were sig-
nificantly increased in the low AKBR rates of patients.9
In view of this result, our data suggest that normother-
mic CPB is not only advantageous for glucose and oxy-
gen metabolism in tissues, but also leads to a better sys-
temic response to the CPB.
The use of moderate systemic hypothermia has been
believed to be the most important measure in protect-
ing vital organs during CPB. However, recent advances
in CPB instruments and equipment (oxygenators and
efficient pumps), which have increased the biocompat-
ibility of these devices, improved oxygenation, and
increased blood flow, may have altered the importance
of hypothermic perfusion.
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